The ERas gene promotes the proliferation of and formation of teratomas by mouse embryonic stem (ES) cells. However, its human orthologue is not expressed in human ES cells. This implies that the behavior of transplanted mouse ES cells would not accurately reflect the behavior of transplanted human ES cells and that the use of nonhuman primate models might be more appropriate to demonstrate the safety of human ES cell-based therapies. However, the expression of the ERas gene has not been examined in nonhuman primate ES cells. In this study, we cloned the cynomolgus homologue and showed that the ERas gene is expressed in cynomolgus ES cells. Notably, it is also expressed in cynomolgus ES cell-derived differentiated progeny as well as cynomolgus adult tissues. The ERas protein is detectable in various cynomolgus tissues as assessed by immunohistochemisty. Cynomolgus ES cell-derived teratoma cells, which also expressed the ERas gene at higher levels than the undifferentiated cynomolgus ES cells, did not develop tumors in NOD/Shi-scid, IL-2Rγ null (NOG) mice. Even when the ERas gene was overexpressed in cynomolgus stromal cells, only the plating efficiency was improved and the proliferation was not promoted. Thus, it is unlikely that ERas contributes to the tumorigenicity of cynomolgus cells. Therefore, cynomolgus ES cells are more similar to human than mouse ES cells despite that ERas is expressed in cynomolgus and mouse ES cells but not in human ES cells.
INTRODUCTION
event in mammalian evolution. It is intriguing to speculate that some of the differences in the proliferation rate or other properties of mouse and human ES cells (9,13) The ERas gene promotes the growth of and formation of teratomas by mouse ES cells by producing a constitu-are related to the differences in expression of this constitutively active ERas gene. It may also imply that the tively active ERas protein and is not expressed in mouse ES cell-derived differentiated progeny or mouse tissues behavior of transplanted mouse ES cells does not accurately reflect the behavior of transplanted human ES (22). Disruption of the ERas gene in mouse ES cells by homologous recombination results in a significantly cells and that the use of nonhuman primate models (11, 21, 25) would be more appropriate to demonstrate reduced proliferation rate and a reduced tumorigenic potential without loss of pluripotency (22) . Although the the safety (tumorigenicity) of human ES cell-based therapies (12). However, the expression of the ERas gene ERas gene is expressed in divergent species such as mice, dogs, and cows, it is not expressed in humans has not been examined in nonhuman primate ES cells (19, 24) . Here, we show that the ERas gene is expressed (1, 12, 17) . Its inactivation is likely a relatively recent in cynomolgus ES cells unlike human ES cells. In addi-kit (Takara, Shiga, Japan) with an oligo dT primer. The resulting cDNA was subjected to PCR with this primer tion, the ERas gene is widely expressed in adult cynomolgus tissues. However, its forced expression in cyno-set. The PCR product was sequenced with the ABI Prism 310 (Applied Biosystems, Foster, CA, USA). The molgus cells even at high levels was not related to tumorigenesis. Therefore, cynomolgus ES cells are more sequence analysis was performed with Genetyx-Mac software (Genetyx Corporation, Tokyo, Japan). We pre-similar to human than mouse ES cells despite that ERas is expressed in cynomolgus and mouse ES cells but not viously constructed the plasmids pPyCAG-EGFP-gw-IP (expressing EGFP) and pPyCAG-EGFP-gw-IP-mouse in human ES cells.
ERas (expressing EGFP-mERas) (22). The cDNA en-
MATERIALS AND METHODS
coding the human or cynomolgus ERas gene was inserted Cell Culture and Differentiation into pPyCAG-EGFP-gw-IP to construct pPyCAG-EGFPgw-IP-human ERas (expressing EGFP-human ERas) or A cynomolgus ES cell line (CMK6) (19), its subline pPyCAG-EGFP-gw-IP-cynomolgus ERas (expressing (CMK6G) stably expressing enhanced green fluorescent EGFP-cynomolgus ERas), respectively. The insert was protein (EGFP) (20) , and a human ES cell line (SA181, confirmed by DNA sequencing. The plasmids were Cellartis AB, Göteborg, Sweden) (10) were maintained transfected into cynomolgus stromal cells using Lipofecon a feeder layer of mitomycin C (Kyowa, Tokyo, Jatamin 2000 (Invitrogen). The transfected cells were sepan)-treated mouse (BALB/c, Clea, Tokyo, Japan) emlected in the presence of puromycin (5 µg/ml). bryonic fibroblasts (MEFs) as previously described (10, 19) . Confluent ES cells were dissociated from the feeder layer using 0.1% collagenase type IV (Invitrogen, Transplantation Carlsbad, CA, USA). Cynomolgus stromal cells were Cells (1 × 10 7 /site) were transplanted into the thigh obtained from cultured adherent cells of cynomolgus muscle of immunodeficient NOD/Shi-scid, IL-2Rγ null bone marrow.
(NOG) mice which were purchased from Central Insti-For neural differentiation from cynomolgus ES cells, tute for Experimental Animals (Kanagawa, Japan). Cyastrocyte-conditioned medium (ACM) was prepared by nomolgus ES cell-derived teratomas were generated culturing astrocytes obtained from mouse fetal cerebra after in utero transplantation of cynomolgus ES cells in Dulbecco's modified Eagle's medium (DMEM)/F12 into fetal sheep as described previously (23) . Adherent medium containing an N2 supplement (Invitrogen) (15) . cells from the teratomas were propagated in DMEM Colonies of cynomolgus ES cells (800-1000 µm in di-(Sigma-Aldrich) supplemented with 10% fetal bovine ameter) were plucked from the feeder layer using a glass serum (FBS) (HyClone, Logan, UT, USA). All expericapillary and transferred into nonadhesive bacteriologiments were performed in accordance with the Jichi cal dishes each containing ACM supplemented with 20
Medical University Guide for Laboratory Animals. Exng/ml of recombinant human fibroblast growth factor-2 perimental procedures were approved by the Animal (FGF-2) (R&D, Minneapolis, MN, USA). The colonies Care and Use Committee of Jichi Medical University. were cultured for 12 days, giving rise to neural stem cells, which were plated onto poly-L-lysine/laminin (Sigma-Aldrich, St. Louis, MO, USA)-coated dishes and Reverse Transcription (RT)-PCR cultivated for 7 days in Neurobasal medium supple-cDNA was prepared from each sample as mentioned mented with 2% B-27 (both from Invitrogen), 20 ng/ml above and subjected to PCR with the following primer of FGF-2, and 20 ng/ml of recombinant human epidersets: for Oct-4, 5′-GGA CAC CTG GCT TCG GAT Tmal growth factor (R&D). After the medium was re-3′ and 5′-TTC GCT TTC TCT TTC GGG C-3′; and for placed with ACM and 14 days of culture, the neural glyceraldehyde-3-phosphate dehydrogenase (GAPDH), stem cells differentiated into neurons (16).
5′-CCC TGG CCA AGG TCA TCC ATG ACA AC-3′ ERas Cloning and Transfection and 5′-CCA GTG AGC TTC CCG TTC AG-3′. Amplification conditions were 30 cycles of 95°C for 60 s, Based on the human ERas cDNA sequence in Genbank (accession No. NM 181532), the primer set 58°C for 60 s, and 72°C for 60 s. PCR without the initial RT was also conducted to rule out DNA contamination. 5′-CAT GGA GCT GCC AAC AAA GCC TG-3′ and 5′-TGT GTC CCT CAA AGC TAG TTG CCT-3′ was de-For real-time quantitative RT-PCR, a QuantiTect SYBR Green PCR kit (Qiagen) and the ABI Prism 7000 (Ap-signed for the cynomolgus ERas' complete coding sequence. Total RNA was extracted from cynomolgus ES plied Biosystems) were used, and amplification conditions were 40 cycles of 95°C for 60 s, 58°C for 60 s, cells using the EZ1 RNA universal tissue kit (Qiagen, Hilden, Germany) with RNase-Free DNase Set (Qia-and 72°C for 60 s. The gene expression levels were adjusted based on those of the internal control GAPDH. gen), and reverse-transcribed using the RNA LA PCR
Immunoblotting
Diego, CA, USA). To detect ERas, cells were fixed using fixation/permeabilization buffer (eBioscience, San Preparation of cell lysates and Western blot analyses Diego, CA, USA) for 2 h at 4°C and then incubated with were performed as described previously (22). Briefly, Alexa Fluor 647 (Invitrogen)-conjugated rabbit anticells (1 × 10 7 ) were washed twice with ice-cold phosserum against ERas for 60 min at 4°C. Data acquisition phate-buffered saline (PBS) and suspended in the buffer and analysis were performed using CellQuest software containing 10 mM Tris-HCl (pH 7.5), 1 mM MgCl 2 , and (BD Pharmingen). Fluorescence-conjugated, irrelevant the 1× Complete Protease Inhibitors (Roche, Basel, Abs served as negative controls. Switzerland), followed by incubation on ice for 30 min. These samples were disrupted with Dounce tissue ho-Cell Proliferation Assay mogenizer (Wheaton, NJ, USA) and added with 1 M Total cell numbers and proliferating cell numbers NaCl to a final concentration of 150 mM. For lysis,
were measured with Cell Counting Kit-8 (Dojindo) and these samples were added with a final concentration of with Cell Proliferation ELISA, BrdU (colorimetric) 5% SDS, 1% NP-40, and 1% deoxicorate acids, fol-(Roche), respectively. For Cell Counting Kit-8, cells lowed by incubation on ice for 10 min. The samples were seeded in 96-well plates at 5 × 10 3 per well and were then centrifuged at 12,000 × g for 30 min at 4°C, measured after 6, 24, 36, 48, and 80 h of incubation and supernatants were collected. The protein concentraaccording to the manufacturer's instructions. For Cell tions were measured by the Bio-Rad Bradford assay Proliferation ELISA, cells were seeded in 96-well plates (BioRad Laboratories, CA, USA). An equal amount of at 2 × 10 3 per well and measured after 24, 36, 48, 72, protein (10 µg per lane) was electrophoresed on 12.5% and 96 h of incubation. Significant differences were expolyacrylamide gel (Atto, Tokyo, Japan) and blotted amined using the t-test. onto a PVDF membrane (Immobiron; Millipore, MA, USA). The membrane was blocked by TBST containing RESULTS AND DISCUSSION 5% w/v Amersham ECL-Blocking Agent (GE Health-Cynomolgus Cells and Tissues Express ERas care, Buckinghamshire, UK) and then incubated with
We first cloned and sequenced the cynomolgus orthorabbit antiserum against mouse ERas (22) overnight at logue of the ERas gene from cDNA of the undifferenti-4°C. After washed with TBST, the membrane was incuated cynomolgus ES cells (Fig. 1A) . The translated bated with anti-rabbit IgG HRP (Jackson Laboratory, amino acid sequence showed a higher degree of homol-CA, USA) at room temperature for 60 min. Signal was ogy to human than mouse ERas (99% vs. 75%) ( Fig.  detected using Amersham ECL Plus Western Blotting 1B). We could not detect the ERas protein in cynomol-Detection reagents (GE Healthcare) according to the gus ES cells by flow cytometry, implying its weak exmanufacturer's protocol and visualized on the LAS 3000 pression (data not shown). mini (Fujifilm, Tokyo, Japan).
Next, we examined the expression of the ERas gene Immunohistochemistry in adult cynomolgus tissues by RT-PCR. Using a primer set to cover the entire coding region, the amplicons from For the immunofluorescent staining of frozen secall nine somatic tissues were the same size as that from tions, tissues were fixed with 4% paraformaldehyde. The cynomolgus ES cells ( Fig. 2A ). The PCR product was sections were labeled with rabbit anti-serum against sequenced to confirm that it was the ERas gene. This mouse ERas (22). The primary antibody (Ab) was declearly shows that a full-length version of the ERas gene tected with a Tyramide Signal Amplification Kit (Inis transcribed in cynomolgus tissues, despite that ERas vitrogen). After nuclei were stained with DAPI (Donis not expressed in mouse tissues (22). jindo, Kumamoto, Japan), the sections were observed
We then examined the protein expression in adult cywith a confocal laser scanning microscope (Olympus, nomolgus tissues by immunohistochemistry. Immu-Tokyo, Japan). For immunohistochemistry, tissues were noblotting revealed that the antibody reacts to human fixed with 4% paraformaldehyde and embedded in parand cynomolgus ERas as well as mouse ERas, although affin. To identify GFP-positive cells, the sections were the antibody was generated against recombinant mouse stained with rabbit anti-GFP Ab (Clontech, Palo Alto, ERas (22) (Fig. 2B ). In addition, it specifically reacts to CA, USA), reacted with the Dako EnVision+ System ERas (25 kDa) and does not react to other Ras family HRP (Dako, Copenhagen, Denmark), and visualized proteins (N-, H-, or K-Ras; 21 kDa) in cynomolgus cells with 3,3′-diaminobenzide tetrahydrochloride (Dojindo).
expressing these Ras genes (Fig. 2B ). Using this anti-Nuclei were counterstained with hematoxylin.
body, we detected ERas-positive cells in all tissues Flow Cytometry tested (brain, thymus, intestine, and ovary) ( Fig. 2C) . At a higher magnification, it turned out that ERas is local-The expression of GFP and ERas was analyzed using a FACS Calibur flow cytometer (BD Pharmingen, San ized on the cytoplasmic membrane as expected (Fig. 2D). We also tested mouse tissues, but ERas-positive sages at a dilution of 1:4 to 1:8. Quantitative RT-PCR showed that the ERas gene expression levels were even cells were not detectable (Fig. 2C) . Taken together, the ERas protein is indeed expressed in cynomolgus tissues, higher in the cultured teratoma cells than in the undifferentiated cynomolgus ES cells (Fig. 3B ). Then, we trans-unlike in murine tissues.
The expression of the ERas gene becomes undetect-planted 1 × 10 7 cultured teratoma cells expressing the ERas gene (GFP-positive, passage 3) into the thigh mus-able after the differentiation of mouse ES cells (22). We examined the expression of the ERas gene after the dif-cle of NOG mice (n = 3), and examined the tumorigenicity of the cells. NOG mice were used as recipients, ferentiation of cynomolgus ES cells. Cynomolgus ES cell-derived neurons and teratoma cells were examined because they are more immunodeficient than other immunodeficient mice and transplanting to NOG mice is for the expression of ERas as well as Oct-4, a pluripotent marker of ES cells. They were positive for ERas the most sensitive assay to detect tumorigenesis (7,14). However, no tumor developed after 2.5 months, al-but negative for Oct-4 ( Fig. 3A) . Although cynomolgus ES cell-derived neurons were fragile and scarcely sur-though the transplanted cell progeny (GFP positive) were detected in every specimen (Fig. 3C ). On the other vived after dissociation from the culture dish, adherent teratoma cells could be cultured for more than six pas-hand, undifferentiated cynomolgus ES cells formed tera- , it reacts to hERas and cyERas as well as mERas. In addition, it does not react to cynomolgus other Ras family proteins (N-, H-, or K-Ras; 21 kDa). ERas (25 kDa) fused with EGFP (26 kDa) is detectable at 51 kDa. In mERas-transfected cells, ERas alone released from the fusion protein was also detected. (C) Using the anti-ERas antibody, ERas-positive cells (red) were detected in cynomolgus brain, thymus, intestine, and ovary. Control indicates the staining of cynomolgus brain without the primary ERas antibody. Although the primary antibody to ERas was originally developed for mouse ERas and should react more strongly to mouse than cynomolgus ERas, no positive signals were detected in mouse brain. (D) The ERas fluorescence with or without DAPI is shown at a higher magnification of both cynomolgus brain and thymus. ERas was detected on the cytoplasmic membrane. tomas in all NOG mice. Taken together, cynomolgus ES stromal cells with a plamid expressing the cynomolgus or mouse ERas, EGFP, and puromycin resistance genes. cell-derived differentiated progeny and teratoma cells also express the ERas gene, but do not produce tumors Transfectants were obtained by treatment with puromycin and more than 90% of the cells expressed EGFP in vivo. (Fig. 4A) . These transfectants did not show significant ERas Overexpression in Cynomolgus Cells morphological changes. Quantitative RT-PCR showed that the transfected cells expressed approximately 1000 To examine whether the cynomolgus ERas contributes to cell proliferation, we transfected cynomolgus times more ERas than undifferentiated cynomolgus ES The plasmids expressing the cynomolgus or mouse ERas, EGFP, and puromycin resistance genes were transfected into cynomolgus stromal cells. After puromycin selection, more than 90% of cells expressed EGFP (upper). The ERas expression was also detected by flow cytometry (lower). (B) The level of cynomolgus ERas gene expression was 1000 times higher in the cynomolgus ERas-transfected cells (cyERas) than in naive cynomolgus ES cells (CMK6) or mock-transfected cells by quantitative RT-PCR. The gene expression levels were adjusted using the internal control GAPDH. (C) The mock-, cynomolgus ERas (cyERas)-, and mouse ERas (mERas)transfected cells were plated at 5 × 10 3 per well and total cell numbers were measured after 6, 24, 36, 48, and 80 h of incubation (upper). The mock-, cyERas-, and mERas-transfected cells were plated at 2 × 10 3 per well and proliferating cell numbers were measured after 24, 36, 48, 72, and 96 h of incubation (lower). The cyERas-and mERas-transfected cells showed larger total cell or proliferating cell numbers after plating than the mock-transfected cells, but did not show any more rapid proliferation thereafter. Statistical differences with the t-test are indicated: *p < 0.01 for the cyERas-versus mock-transfected cells, **p < 0.01 for the mERas-versus mock-transfected cells. 
